Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.22 +0.40 (+10.55%)
As of: Oct 21, 2026 · 11:04 AM EDT

Adial Pharmaceuticals (ADIL) Convertible Debt (2017 - 2018)

Updated

Adial Pharmaceuticals' Convertible Debt came in at $132,854 for Q2 2018.

Analysis

Adial Pharmaceuticals (ADIL) Convertible Debt (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Adial Pharmaceuticals 19.46 Mn -24.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 132,854.00
Dec 31, 2017 132,854.00
API Access

Adial Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ADIL&period=max&api_key=YOUR_API_KEY